The rebrand comes on the heels of the company acquiring Cook Biotech and Collagen Solutions. Evergen is the industry’s only CDMO to offer a comprehensive portfolio of allograft and xenograft biologics, according to a Dec. 17 news release.
Evergen’s regenerative medicine portfolio includes products for orthopedics, neurosurgery and sports medicine.
From new partnerships to product launches, here are 12 key developments in orthobiologics during the first quarter of 2025. 1.…
Miach Orthopaedics' BEAR (bridge-enhanced ACL restoration) implant is now available to treat children and adolescents with anterior cruciate ligament tears…
Atreon Orthopedics earned expanded FDA 510(k) clearance for its Rotium bioreabsorbable wick, according to a March 6 news release.
Comments are closed.